Hereditary in Biological Technology
Navigation Links
Hereditary in Biological Technology
... [human]) as a treatment for acute attacks of hereditary angioedema (HAE). The FDA has requested an ... Castaldo, president of the U.S. and International hereditary Angioedema Association. "Cinryze as a ... an injection rate of 1 mL per minute.
About hereditary Angioedema (HAE)
HAE is a rare, severely ...
... strains, and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package ...
... for comprehensive information and education on age-related macular degeneration (AMD) in a unique watch-and-learn video format. AMD is a progressive, hereditary eye disease that is the leading cause of blindness in Americans age 50 or older. On the site, visitors can learn about basic eye anatomy, ...
... and Mylan, and under the Hatch Waxman Act has 45 days to determine if it will file patent infringement suits. Pipeline FIRAZYR - for hereditary angioedema ("HAE") in the US - In December 2008 Jerini AG ("Jerini") met with the US Food and Drug Administration ("FDA") to discuss the ...
... To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/cslbehring/32474/ Von Willebrand disease (VWD) is the most common hereditary bleeding disorder in the United States, and is caused by a deficiency or abnormality of von Willebrand factor in the blood. According to the U.S. ...
... of certain customary terms and conditions, including approval by relevant merger control authorities. The proposed acquisition will add Jerini's hereditary angioedema ("HAE") product, FIRAZYR(R) (icatibant), (expected to be launched in the EU in H2 2008) to Shire's Human Genetic Therapies ("HGT") ...
... and investors extensive prospects for the treatment of this disease." About cystic fibrosis Cystic fibrosis is the most common life-threatening hereditary disease among Caucasian population. The disease is caused by a mutation in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene found ...
... food 2 hours before and 1 hour after taking dose. Lactose Since the capsules contain lactose, Tasigna is not recommended for patients with rare hereditary problems of galactose intolerance, severe lactase deficiency, or of glucose-galactose malabsorption. Pregnancy Fetal harm can occur when Tasigna ...
... Raptor's clinical development subsidiary, Bennu Pharmaceuticals Inc. ("Bennu"), plans to evaluate cysteamine in patients with HD. HD is a rare and hereditary neurological disease thought to occur in approximately 1 out of every 20,000 people resulting in around 20,000 patients in the U.S. presently. There ...
... clotting factors (Factor VIII). Hemophilia A (often called classic hemophilia) accounts for about 80% of all hemophilia cases. Hemophilia A is a hereditary disorder in which the clotting ability of the blood is impaired and excessive bleeding results. Small wounds and punctures are usually not a problem, ...
... for the hemostasis laboratory. This test represents a differentiated continuation of our menu expansion program." FII and FV are the most common hereditary risk factors for venous thrombosis and are key in the determination of genetic predisposition to the condition and the need for prophylactic ...
... its lead compound, SNT-MC17 (INN: idebenone), in the treatment of Friedreich's Ataxia (FRDA), Duchenne Muscular Dystrophy (DMD) and Leber's hereditary Optic Neuropathy (LHON). Another clinical program is investigating JP-1730 (INN: fipamezole) for the treatment of Dyskinesia in Parkinson's Disease ...
ViroPharma Incorporated Honored by the National Organization for Rare Disorders
... to market for a rare and devastating disorder -- hereditary angioedema (HAE). HAE is a rare, severely ... injection rate of 1 mL per minute. About hereditary Angioedema HAE is a rare, severely ... attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor ...Waters Corporation Gives Boost to Clinical Research Programs at University of Sherbrooke Hospital
... and assessment of treatments for specific hereditary diseases, as well as for patient surveillance and ... at the cutting edge of genetics in detecting hereditary metabolic diseases and in research into assessing ... well as other devices dedicated to screening for hereditary diseases (mass spectrometers), surgical and ...ViroPharma To Acquire Lev Pharmaceuticals
... Late Stage Product Targeting Life-threatening hereditary Angioedema Disease with Limited ... as a replacement therapy for patients with hereditary angioedema (HAE), also known as C1 esterase ... number of other serious inflammatory disorders. hereditary angioedema, or C1-INH deficiency, is a dangerous ...Otonomy Introduces Scientific Advisory Board
... Friedman, M.D., Ph.D. Dr. Friedman is the research section chief of hereditary ear disorders in the department of Cell and Molecular Biology at the House ... and St. Vincent Medical Center. His area of expertise is the study of hereditary deafness. Dr. Friedman served as a resident in the division of ...Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin'
... a physician to have them re-evaluated. Nasal allergies can be hereditary : If parents have indoor or outdoor allergies, it is possible that their children will also. Nasal allergies tend to be hereditary -- although the exact genetic factors are not fully understood. ...ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
... Initiated commercial launch of Cinryze for routine prophylaxis of hereditary angioedema (HAE); Developed and successfully launched Cinryze ... against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing ...Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... alfa free of charge initially, in order to provide access to patients as quickly as possible. FIRAZYR(R) - for the treatment of hereditary angioedema ("HAE") - In June 2009, Shire initiated a Phase 3 study in patients with acute attacks of HAE, known as the FAST-3 trial, which is ...New Report Just Published: World Prostate Cancer Therapeutics Market Report
... of Prostate Cancer II-27 TNM Staging II-27 T-Staging Analysis of Prostate Cancer II-27 Genetic & Non-Genetic Factors II-28 hereditary or Genetic Factors II-28 Non-Genetic or Environmental Factors II-28 Table 17: Prostate Cancer Incidence/Mortality Rate by Race & ...Fruit fly steps in to fight human disease
... and the Katholieke Universiteit Leuven, and appears in the Proceedings of the National Academy of Sciences (PNAS). Charcot-Marie-Tooth is a hereditary disorder of the peripheral nervous system that affects 1 in 2,500 people worldwide. Patients suffer from progressive motor impairment, muscle wasting ...Video: Varicose Veins, Much More Than a Cosmetic Issue, Can Prove a Health Risk
... own needs for last. My work as a nurse has taught me to look for signs from my body, and in the bodies of patients, and to keep special track of the hereditary diseases such as varicose veins," said Iliana Portela, Registered Nurse with Vein Clinics of America. "To be the strong support our family needs, ...ViroPharma to Present at Two June Healthcare Conferences
... commercializes Cinryze(TM) (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package ...ViroPharma Incorporated Reports First Quarter 2009 Financial Results
... commercializes Cinryze(TM) (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package ...ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
... strains, and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package ...Publication of Shire plc's Annual Report 2008
... pre-clinical development for the Specialty Pharmaceuticals area. Human Genetic Therapies Treatments for Angioedema FIRAZYR for hereditary angioedema ('HAE') in the US FIRAZYR is a treatment for acute HAE which Shire added to the portfolio through its acquisition of a majority ...... strains, and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package ...
... for comprehensive information and education on age-related macular degeneration (AMD) in a unique watch-and-learn video format. AMD is a progressive, hereditary eye disease that is the leading cause of blindness in Americans age 50 or older. On the site, visitors can learn about basic eye anatomy, ...
... and Mylan, and under the Hatch Waxman Act has 45 days to determine if it will file patent infringement suits. Pipeline FIRAZYR - for hereditary angioedema ("HAE") in the US - In December 2008 Jerini AG ("Jerini") met with the US Food and Drug Administration ("FDA") to discuss the ...
Chronic Lung Disease - Axentis Pharma Attracts Investment Interest
... of the microbial cell, which leads to rapid cell death. About cystic fibrosis Cystic fibrosis is the most common life-threatening hereditary disease amongst Caucasian populations. The disease is caused by a mutation in the CFTR (cystic fibrosis transmembrane conductance regulator) gene ...Confirmation of HGT Business Day - 18th November 2008
... senior team. In addition, Shire is pleased to announce that Pr. Marco Cicardi, M.D. University of Milan and Specialist in Angioedema will present on hereditary Angioedema. Notes to editors Shire Plc Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on ...Shire's New Product Portfolio Delivers Strong Quarterly Performance
... Commission. Launches will continue across Europe as reimbursement negotiations proceed. FIRAZYR has orphan designation and is the first hereditary angiodema ("HAE") product to receive approval throughout the European Union; - INTUNIV(TM) (guanfacine) for use in children and adolescents ...Researchers develop new model for cystic fibrosis
... of the disease and may also speed discovery of new treatments. The study is published in the Sept. 26 issue of Science. CF is a common hereditary disease that affects multiple organ systems, including the intestines, pancreas, and lung. Mice with CF-causing mutations have helped researchers ...Video: Moms Raise 'Red Flag' About the Dangers of Widely Undiagnosed Bleeding Disorder
... Willebrand Disease NEW YORK, Sept. 23 /PRNewswire/ -- While an estimated 2.8 million Americans are affected by the most common hereditary bleeding disorder, von Willebrand disease (VWD), most don't even know they have it. VWD affects both men and women, but according to the Centers for ...Abeome Forms First Class Scientific Advisory Board
... Cancer Scholar by the Georgia Cancer Coalition. His long-term research focus has studied molecular genetics of ovarian cancer with emphasis on hereditary predisposition. Linda Matsuuchi, PhD, Associate Director of the Life Sciences Institute at the University of British Columbia, has a distinguished ...... To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/cslbehring/32474/ Von Willebrand disease (VWD) is the most common hereditary bleeding disorder in the United States, and is caused by a deficiency or abnormality of von Willebrand factor in the blood. According to the U.S. ...
... of certain customary terms and conditions, including approval by relevant merger control authorities. The proposed acquisition will add Jerini's hereditary angioedema ("HAE") product, FIRAZYR(R) (icatibant), (expected to be launched in the EU in H2 2008) to Shire's Human Genetic Therapies ("HGT") ...
Incorrectly cleaved protein leads to schizophrenia
... delusions, hallucinations, chaotic behavior, etc. The origin of the disease Up to now, no clear cause of schizophrenia has been found, although hereditary factors certainly play a role in the development of the disease. In addition, living and working conditions determine the disorder's progress. ...... and investors extensive prospects for the treatment of this disease." About cystic fibrosis Cystic fibrosis is the most common life-threatening hereditary disease among Caucasian population. The disease is caused by a mutation in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene found ...
... food 2 hours before and 1 hour after taking dose. Lactose Since the capsules contain lactose, Tasigna is not recommended for patients with rare hereditary problems of galactose intolerance, severe lactase deficiency, or of glucose-galactose malabsorption. Pregnancy Fetal harm can occur when Tasigna ...
... Raptor's clinical development subsidiary, Bennu Pharmaceuticals Inc. ("Bennu"), plans to evaluate cysteamine in patients with HD. HD is a rare and hereditary neurological disease thought to occur in approximately 1 out of every 20,000 people resulting in around 20,000 patients in the U.S. presently. There ...
... clotting factors (Factor VIII). Hemophilia A (often called classic hemophilia) accounts for about 80% of all hemophilia cases. Hemophilia A is a hereditary disorder in which the clotting ability of the blood is impaired and excessive bleeding results. Small wounds and punctures are usually not a problem, ...
... for the hemostasis laboratory. This test represents a differentiated continuation of our menu expansion program." FII and FV are the most common hereditary risk factors for venous thrombosis and are key in the determination of genetic predisposition to the condition and the need for prophylactic ...
Cord Blood America CEO Matthew Schissler Interviewed by BIONOVA, Greece's Leading Biotech Magazine
... in the treatment of leukemia, breast cancer, lymphoma, Hodgkin's Disease, aplastic anemia, sickle cell anemia, various other cancers, blood diseases, hereditary and genetic conditions and immune system disorders," Mr. Schissler said in the interview. "As stem cell transplants become routine, they may be used ...CSL Behring Expands Into Middle East Market with Haemate(R) P
... High levels of Type III von Willebrand Disease, a serious, hereditary bleeding disorder, found in region KING OF PRUSSIA, Pa., Dec. 19 /PRNewswire/ -- CSL Behring today announced that Iran's Ministry ...Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
... studies, XL880 inhibited its targets with nanomolar potency, and retained potent activity against mutationally activated forms of MET found in hereditary papillary renal cell carcinomas. The compound also demonstrated dose-dependent tumor growth inhibition in models of breast cancer, colorectal cancer, ...... its lead compound, SNT-MC17 (INN: idebenone), in the treatment of Friedreich's Ataxia (FRDA), Duchenne Muscular Dystrophy (DMD) and Leber's hereditary Optic Neuropathy (LHON). Another clinical program is investigating JP-1730 (INN: fipamezole) for the treatment of Dyskinesia in Parkinson's Disease ...
Rice Centromere, Supposedly Quiet Genetic Domain, Surprises
... the scientific understanding of chromosomes, the molecular structures that are found in all animal and plant cells, and are the essential carriers of hereditary information, enabling the processes of cell division and replication. At a practical level, the work is a necessary step toward science's ...Children's Hospital chooses Camtronics for cardiology IT system
... system CardioIMS. The system will be implemented in the Columbus Children's Heart Center , which addresses the needs of children and adults with hereditary heart defects. The choice was based on an in-depth study of the Center's administrative and clinical needs, looking specifically at the issue of ...Third Wave to seek FDA clearences after expanding pipeline
... over some key management positions. Read more here. Third Wave expects to seek FDA clearance for in-vitro diagnostics for Factor V Leiden, a hereditary blood disease, and Factor II prothrombin deficiency, a form of hemophilia. The company said the products are already on the market, but FDA clearance ...Other Contentssprainsportssportssportssportssportssprainssprainssprainssquamoussquamoussquamoussquamoussquamoussputumsputumspurspurspurspursquintstein
Breaking Biology News(10 mins):The Academy of Natural Sciences and Temple Press revive rare natural history work in new book 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 4Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 5Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 6Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 1Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 2Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 3Chefs Participate in Weight Watchers National Lose For Good 28TM 29 Campaign With Chefs Lose For Good Initiative at the 2009 Food Network New York Cit 57365 4Capital BlueCross to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 57361 1Capital BlueCross to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 57361 2CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 1CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 2CELLECTA INC to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research Inc 14095 3
Breaking Medicine News(10 mins):Health News:Patriot Scientific Corporation Announces New Director 2Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 2Health News:Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards 3Health News:Washington Regional Partners with U.S. Preventive Medicine to Bring a New Level of Preventive Health Care Services to Northwest Arkansas 2Health News:Washington Regional Partners with U.S. Preventive Medicine to Bring a New Level of Preventive Health Care Services to Northwest Arkansas 3Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Industry Coalition Reissues Advisory Against Use of Dietary Supplements as Swine Flu Remedy, Cure 2Health News:Industry Coalition Reissues Advisory Against Use of Dietary Supplements as Swine Flu Remedy, Cure 3
Other TagsRegardDeatDeatDeatBusterairwaysGaysIBSGaiGaiGaiGaiOther Tagsrelief 2relief 3relief 4relief 5relief 6relief 7relief 8relief 9relief 10pain 2pain 3pain 4pain 5pain 6pain 7pain 8pain 9pain 10term 2term 3term 4term 5term 6term 7term 8term 9term 10long 2long 3long 4long 5long 6long 7long 8long 9long 10offers 2offers 3offers 4offers 5offers 6offers 7offers 8offers 9offers 10procedure 2procedure 3procedure 4procedure 5procedure 6procedure 7procedure 8procedure 9procedure 10fertilized 2cloned 2cloned 3glands 2airway 2fibrosis 2[0] Patriot Scientific Corporation Announces New Director[0] Secure-24 and ATMP Consulting Group Launch Partnership for Private Practice Physicians to Meet IT and Electronic Medical Record Standards [1] Washington Regional Partners with U.S. Preventive Medicine to Bring a New Level of Preventive Health Care Services to Northwest Arkansas[0] Lilly Announces the First 300-unit Vial of Insulin[1] Industry Coalition Reissues Advisory Against Use of Dietary Supplements as Swine Flu Remedy, Cure
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |